Hipcricket (HIPP) 10-Q 9 Jan 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	9 Months Ended
	Nov. 30, 2013	Jan. 03, 2014	Jun. 30, 2013
Document And Entity Information	'	'	'
Entity Registrant Name	'Hipcricket, Inc.	'	'
Entity Central Index Key	'0001137204	'	'
Document Type	'10-Q	'	'
Document Period End Date	30-Nov-13	'	'
Amendment Flag	'false	'	'
Current Fiscal Year End Date	'--02-28	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Filer Category	'Accelerated Filer	'	'
Entity Public Float	'	'	$130,248
Entity Common Stock, Shares Outstanding	'	154,576,433	'
Document Fiscal Year Focus	'2014	'	'
Document Fiscal Period Focus	'Q3	'	'

CONSOLIDATED_BALANCE_SHEETS_Un

CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)	Nov. 30, 2013	Feb. 28, 2013
ASSETS	'	'
Cash and cash equivalents	$4,855,811	$4,352,691
Restricted cash	214,698	214,455
Accounts receivable, net	6,432,173	5,707,019
Prepaid expenses and other current assets	483,756	772,029
Total current assets	11,986,438	11,046,194
Intangible assets held for sale	'	3,500,000
Property and equipment, net	162,173	82,737
Goodwill	35,060,183	35,060,183
Intangible assets, net	25,478,755	25,812,037
Deposits	260,806	238,011
TOTAL ASSETS	72,948,355	75,739,162
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'
Accounts payable	4,042,497	4,812,086
Accrued liabilities	2,568,704	2,614,365
Deferred revenue	572,749	851,847
Line of credit	1,356,807	'
Total current liabilities	8,540,757	8,278,298
Deferred income tax liability, net	3,517,652	3,517,652
Accrued liabilities	30,138	82,002
TOTAL LIABILITIES	12,088,547	11,877,952
STOCKHOLDERS' EQUITY:	'	'
Common stock, $.0001 par value; 250,000,000 shares authorized; 154,576,433 and 129,554,226 shares issued and outstanding, respectively.	15,458	12,955
Additional paid-in capital	186,906,328	175,241,799
Accumulated deficit	-126,061,978	-111,393,544
Total stockholders' equity	60,859,808	63,861,210
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$72,948,355	$75,739,162

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Nov. 30, 2013	Feb. 28, 2013
STOCKHOLDERS' EQUITY:	'	'
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	154,576,433	129,554,226
Common stock, shares outstanding	154,576,433	129,554,226

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Consolidated Statements Of Operations	'	'	'	'
REVENUE	$6,425,887	$7,433,051	$19,884,186	$18,700,622
COST OF REVENUES	3,242,479	3,054,212	9,226,281	7,464,449
OPERATING EXPENSES:	'	'	'	'
Selling and marketing	2,744,070	3,814,930	8,905,565	11,319,153
Technology and development	1,603,450	1,927,193	4,961,799	5,937,333
General and administrative	2,355,094	3,457,777	7,131,207	10,441,082
Depreciation and amortization	1,275,815	1,597,443	3,829,125	4,681,129
Goodwill impairment	'	25,919,000	'	25,919,000
Impairment of intangible assets and investments	464,958	8,667,883	464,958	8,667,883
Total operating expenses	8,443,387	45,384,226	25,292,654	66,965,580
LOSS FROM OPERATIONS	-5,259,979	-41,005,387	-14,634,749	-55,729,407
OTHER INCOME (EXPENSE):	'	'	'	'
Interest income (expense), net	-18,996	-39,856	-33,685	-36,987
Acquisition related contingent consideration	'	7,339,173	'	12,199,730
NET LOSS BEFORE INCOME TAXES	-5,278,975	-33,706,070	-14,668,434	-43,566,664
Income tax benefit	'	'	'	2,618,723
NET LOSS	($5,278,975)	($33,706,070)	($14,668,434)	($40,947,941)
NET LOSS PER SHARE - basic and diluted	($0.04)	($0.31)	($0.11)	($0.41)
WEIGHTED AVERAGE SHARES OUTSTANDING	'	'	'	'
Basic and diluted	145,698,039	108,460,588	135,114,413	99,718,225

CONSOLIDATED_STATEMENT_OF_CHAN

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) (USD $)	Common Stock	Paid-In Capital	Accumulated Deficit [Member]	Total
Beginning balance, Amount at Feb. 28, 2013	$12,955	$175,241,799	($111,393,544)	$63,861,210
Beginning Balance, Shares at Feb. 28, 2013	129,554,226	'	'	'
Stock with warrant subscription fees, Shares	23,875,000	'	'	'
Stock with warrant subscription fees, Amount	2,388	8,971,542	'	8,973,930
Option/Warrant exercise, Shares	10,000	'	'	'
Option/Warrant exercise, Amount	1	2,499	'	2,500
Underwriter services, Shares	354,310	'	'	'
Underwriter services, Amount	35	'	'	35
Board of Director fees, Shares	182,897	'	'	'
Board of Director fees, Amount	19	77,149	'	77,168
Advisory services, Shares	600,000	'	'	'
Advisory services, Amount	60	248,940	'	249,000
Employee share-based compensation	'	2,069,725	'	2,069,725
Warrant expense	'	294,674	'	294,674
Net Loss	'	'	-14,668,434	-14,668,434
Ending Balance, Amount at Nov. 30, 2013	$15,458	$186,906,328	($126,061,978)	$60,859,808
Ending Balance, Shares at Nov. 30, 2013	154,576,433	'	'	'

STATEMENTS_OF_CASH_FLOWS

STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'
Net loss	($14,668,434)	($40,947,941)
Depreciation and amortization	3,829,125	4,681,129
Bad debt expense	24,481	45,569
Non-cash interest expense	'	36,757
Common stock issued for services	326,203	625,000
Loss on sale or disposal of fixed assets	895	400
Share-based compensation expense	2,364,399	4,302,359
Goodwill impairment	'	25,919,000
Deferred income tax benefits	'	-2,618,723
Impairment of intangible assets and investments	464,958	8,667,883
Fair value adjustment of acquisition related contingent consideration	'	-12,199,730
Changes in operating assets and liabilities:	'	'
Accounts receivable	749,635	2,423,366
Prepaid expenses and other current assets	-288,273	68,368
Interest on restricted cash	-243	'
Deposits	22,795	-126,189
Accounts payable and accrued liabilities	-810,382	3,370,578
Deferred revenue	-279,098	131,187
Long-term liabilities	-51,864	-56,551
NET CASH USED IN OPERATING ACTIVITIES	-9,284,117	-10,408,628
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'
Cash paid for purchase of patents	-43,542	-820,139
Cash paid for patent defense costs	-327,369	-2,723,931
Cash paid for acquisition related contingent consideration	'	-3,182,209
Cash paid for long-term investment	'	-200,000
Additions to property and equipment	-170,224	'
NET CASH USED IN INVESTING ACTIVITIES	541,135	6,926,279
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'
Proceeds from sale of common stock, net	8,969,065	6,162,455
Proceeds received from line of credit	1,356,807	'
Proceeds received from issuance of short-term debt	'	450,000
Payment on short-term debt	'	-200,000
Proceeds received from the exercise of stock options and warrants, net	2,500	1,257,160
NET CASH PROVIDED BY FINANCING ACTIVITIES	10,328,372	7,669,615
NET CHANGE IN CASH AND CASH EQUIVALENTS	503,120	-9,665,292
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	4,352,691	11,428,825
CASH AND CASH EQUIVALENTS, END OF PERIOD	4,855,811	1,763,533
SUPPLEMENTAL CASH FLOW INFORMATION:	'	'
Interest paid	33,927	3,100
Income taxes paid	134,727	'
Non-cash investing activity:	'	'
Stock issued for asset purchase	'	3,813,953
Acquisition related contingent consideration settled in stock	'	$10,578,900

ORGANIZATION_AND_BASIS_OF_PRES

ORGANIZATION AND BASIS OF PRESENTATION	9 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 1 - ORGANIZATION AND BASIS OF PRESENTATION	'
	The accompanying unaudited interim financial statements of Hipcricket, Inc. (“Hipcricket,” the “Company,” “we,” or “us”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”), and should be read in conjunction with the audited financial statements and notes thereto contained in our Annual Report on Form 10-K filed with the SEC on May 24, 2013.
	In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosures contained in the audited financial statements for the fiscal year ended February 28, 2013 included in our Annual Report on Form 10-K have been omitted.
	Description of Business
	On August 23, 2013, we changed our company name from Augme Technologies, Inc. to Hipcricket, Inc. Hipcricket®, Augme®, Augme Technologies™, AD LIFE® (“AD LIFE”), AD SERVE®, A+®, Boombox® and the Company logos are trademarks of Hipcricket, Inc.
	We provide mobile advertising and mobile marketing technology and services that empower brands, agencies and media companies to engage customers, drive loyalty and increase sales. Our proprietary software-as-a-service AD LIFE platform (the “Platform”) allows marketers, brands, and agencies to plan, create, test, deploy, and track mobile marketing programs across nearly every mobile channel. Through the use of Consumer Response Tags such as 2D codes, UPC codes, short message service, and image recognition, our Platform facilitates consumer brand interaction and the ability to track and analyze campaign results. Using our patented device-detection and proprietary mobile content adaptation software, AD LIFE solves the mobile marketing industry problem of disparate operating systems, device types, and on-screen mobile content rendering. We also provide business-to-consumer utilities including national mobile couponing solutions, strategic mobile healthcare tools, custom mobile application development and consumer data tracking and analytics. Our products serve advertisers and ad agencies in many vertical markets, including automotive, retail, consumer products, food and beverage, media and broadcast, pharmaceutical and restaurant brands.
	The mobile marketing and advertising landscape, while in its early stages, is highly competitive. Many of the landscape’s significant players are focused on delivering point solutions targeting a specific segment of the mobile marketing and/or advertising landscape.  We differ from the competition by offering complete, end-to-end mobile advertising and marketing solutions delivered through our AD LIFE Platform.
	Our advanced, comprehensive, and fully integrated Platform drives revenue primarily through license fees, marketing campaign fees, and fees associated with certain add-on promotional applications in the Platform. Additional revenue is generated by platform administration and professional service fees related to the mobilization of client content and implementation of marketing campaigns through the Platform.
	Our portfolio of patents covers technical processes and methods that are believed to be a foundational component of behavioral targeting — the automatic provision of customized content to individuals based on information such as past web activity, personal preferences, geography, or demographic data. As of November 30, 2013 we owned 21 U.S. patents. We are pursuing on a selective basis, additional patents that generally relate to targeting, analytics, advanced mobile marketing, customized content delivery, and mobile and networked marketing technology.
	We operate under one reportable segment. In December 2013, we relocated our corporate headquarters to 110 110th Avenue NE, Suite 410, Bellevue, Washington 98004. Additionally, we maintain a presence in New York, Atlanta, Miami, Dallas, Chicago, San Francisco and Los Angeles.
	Liquidity
	As of November 30, 2013 and February 28, 2013, we had accumulated deficits of $126.1 million and $111.4 million, respectively. We are subject to the risks and challenges associated with companies at a similar stage of development including dependence on key individuals, successful development and marketing of our products and services, integration of recent business combinations, competition from alternative products and services and larger companies with greater financial, technical management and marketing resources. Further, we may require additional financing to execute our key business strategies and fund operations. Those funds may not be readily available or may not be on terms that are favorable to us. Certain financing terms could be dilutive to existing shareholders or could result in significant interest or other costs, or require us to license or relinquish certain intellectual property rights.
	We operate in the mobile marketing industry and, accordingly, can be affected by a variety of factors. For example, we believe that any of the following factors could have a significant negative effect on our future financial position, results of operations and cash flows: unanticipated fluctuations in quarterly operating results, adverse changes in our relationship with significant customers or failure to secure contracts with other customers, intense competition, failure to attract and retain key personnel, failure to protect  intellectual property, decrease in the migration trends from traditional advertising methods to digital and mobile media and the inability to manage growth.
	In September 2012, we adopted a restructuring plan which included reducing the number of employees, slowing the pace of investments in our intellectual property (“IP”) portfolio and minimizing variable expenses. We have restructured overall corporate overhead expenses in order to focus our business around our mobile marketing and advertising technology and services. Consistent with this plan, we have settled a majority of our patent litigation cases, while protecting the value of our IP assets, to reduce our ongoing legal costs, downsized our Tucson division which was primarily involved with development and monetization of our IP, streamlined personnel and variable costs, and solidified the management team by appointing new personnel with extensive experience in the mobile marketing and advertising space to lead our sales and engineering teams. We have made substantial improvements in lowering our operating expenses, compared to the same period one year ago. We intend to continue our efforts to minimize cash spend and identify additional cost savings opportunities while carefully investing our resources and protecting our strategic assets to strengthen our position in the mobile marketing and mobile advertising industry.
	During the quarter ended May 31, 2013, we secured an accounts receivable credit facility from Silicon Valley Bank (“SVB”) to help fund our working capital needs, which was amended and restated on November 25, 2013. The revolving loan facility has a two-year term and allows us to borrow up to $5.0 million based upon a formula equal to 90% of eligible accounts receivable, decreasing to 80% of eligible accounts receivable plus the least of (i) 80% of Eligible 120 Day Accounts as defined in the amended and restated loan agreement (the “Amended Agreement”), (ii) $1,000,000, and (iii) 30% of the sum of all eligible accounts plus Eligible 120 Day Accounts after December 31, 2013. The facility is secured by substantially all of our assets. Amounts drawn under the facility accrue annual interest at the prime rate plus 0.75% during a Streamline Period, as defined in the Amended Agreement, and at the prime rate plus 1.25% when a Streamline Period is not in effect. We are required to deliver periodic reports to SVB regarding our ability to meet certain financial and other covenants contained in the loan Amended Agreement. In late July we delivered the report to SVB indicating that as of June 30, 2013, we had breached our minimum tangible net worth covenant and began discussions of a forbearance or waiver agreement with SVB. On November 25, 2013, we entered into the Amended Agreement with SVB. The Amended Agreement retained substantially the same terms as the original loan and security agreement, except the borrowing base was amended as described above and the collateral securing the loan facility was expanded to include our intellectual property. In connection with the execution of the Agreement, we obtained a waiver of our covenant default. As of the November 30, 2013, we had drawn $1.4 million from this line of credit and had approximately $3.2 million available based on our outstanding accounts receivable as of that date. See Note 9 below for additional information about the credit facility.
	On October 4, 2013, we closed a $9.6 million financing transaction with 13 investors, each of which is an “accredited investor” within the meaning of the Securities Act of 1933. The investors purchased units of our securities at $0.40 per unit.  We received net proceeds of $9.0 million, reflecting approximately $581,000 in fees and costs associated with the financing. Each unit consisted of one share of our common stock and a warrant to purchase 0.3 shares of our common stock. An aggregate of 23,875,000 shares of our common stock and warrants to purchase up to 7,162,500 shares of our common stock were purchased in the financing. The warrants have a five year term and an exercise price of $0.60 per share. In connection with the financing, we also entered into a registration rights agreement with each investor pursuant to which we have agreed to file and maintain effectiveness of a registration statement covering the resale of all of the shares of common stock and shares of common stock underlying the warrants sold in the financing. We filed a registration statement on Form S-1 with the SEC on November 4, 2013. The registration statement was declared effective on November 8, 2013.
	In the future, we may need to raise additional cash through equity or debt financings, and/or sell all or part of our patent portfolio, while retaining the rights to use the patents in our technology. There is no certainty that we will have the ability to raise additional funds through debt or equity financings under terms acceptable to us or that we will have the ability to sell all or part of the patent portfolio. If sources of capital are unavailable, or are available only on a limited basis or under unacceptable terms, then we could be required to substantially reduce or discontinue our investments in new customers and new products; reduce selling, marketing, general and administrative costs related to our continuing operations; or limit the scope of our continuing operations. Due to the nature of our operations and financial commitments we may not have the discretion to reduce operations in an orderly manner to a more sustainable level without impacting future operations.
	As of the filing of our Annual Report on Form 10-K for the fiscal year ended February 28, 2013, we no longer met the minimum $75 million public float requirement for use of Form S-3 registration for primary sales of our common stock and therefore are limited in our ability to issue the remaining $41.4 million remaining on our existing Form S-3 and/or to file new shelf registration statements on Form S-3. Until such time as we satisfy the $75 million public float and other requirements for use of Form S-3 registration, we will be required to use a registration statement on Form S-1 to register securities with the SEC or issue such securities in a private placement, which could increase the cost of raising capital.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the amounts reported in the financial statements. We regularly evaluate estimates and judgments based on historical experience and other relevant facts and circumstances. Actual results could differ from those estimates. Significant estimates relate to fair value of assets acquired and liabilities assumed in business combinations, acquisition related contingent consideration, allowances for tax assets, the use of the Black-Scholes pricing model for valuing stock option and common stock warrant issuances, estimates of future cash flows used to evaluate impairment of long-lived assets, revenues earned from percentage of completion contracts and the period in which revenues should be recorded.
	Reclassifications
	Certain reclassifications have been made to prior periods to conform to current reporting. The presentation of our Consolidated Statements of Operations has been adjusted for the reclassification of operating expenses to be presented in the following categories: sales and marketing, technology and development, general and administrative and depreciation and amortization.  The operating expenses for the three and nine months ended November 30, 2012 have been reclassified accordingly.
	Summary of Significant Accounting Policies
	The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and pursuant to the rules and regulations of the SEC. The same accounting policies are followed for preparing the quarterly and annual financial information unless otherwise disclosed.

RESTATEMENT_OF_PREVIOUSLY_ISSU

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	9 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	'
	In this Quarterly Report on Form 10-Q, we are reporting quarterly data for our fiscal quarter ended November 30, 2013, and in some cases providing the comparative data from the same quarter a year ago. As described in our Annual Report on Form 10-K for the fiscal year ended February 28, 2013 filed with the SEC on May 24, 2013, and summarized below, we restated the financial statements for certain quarterly and year-to-date periods, including the quarter ended November 30, 2012. All comparative data for the quarter ended November 30, 2012 is as restated.
	Description of Restatement
	In connection with our financial close process for our fiscal year 2013 financial statements, we concluded that the accounting for our acquisition of Hipcricket, Inc. (“Hipcricket subsidiary”) and JAGTAG, Inc. (“JAGTAG”), both of which occurred during fiscal year 2012, and of GEOS Communications IP Holdings, Inc. (“GEOS”), which occurred during the first quarter of fiscal 2013, was incorrect because deferred income tax liabilities arising from the acquisition accounting were not properly recorded for the differences between the book and tax basis of the acquired assets. The corresponding reduction to the deferred income tax asset valuation allowance was also not properly recognized. The Hipcricket subsidiary and JAGTAG transactions were structured as non-taxable transactions to the acquired companies’ shareholders and therefore considered mergers according to the provisions of IRS Code Section 368(a)(1)(c). To correct the errors related to the Hipcricket subsidiary and JAGTAG transactions, we recorded an increase to goodwill of $13.5 million, an increase to deferred tax liability of $13.5 million, which resulted in a corresponding reduction to the deferred income tax asset valuation allowance of $10.0 million and an increase to income tax benefits of $10.0 million for the quarter ended August 31, 2011 and fiscal year ended February 29, 2012. To correct the errors related to the GEOS transaction, we recorded an increase to the identified intangible asset category of patents of $2.6 million, an increase to deferred income tax liability of $2.6 million, and a corresponding reduction to the deferred income tax asset valuation allowance of $2.6 million and an increase to income tax benefits of $2.6 million for the quarter ended May 31, 2012. As a result of our previously completed impairment analysis performed during the quarter ended November 30, 2012 on certain identified intangibles, we recognized additional impairment expense of $2.6 million to write off the increased value resulting from the adjustments for the GEOS transaction.
	We assessed the impact of the errors relating to the Hipcricket subsidiary and JAGTAG transactions on our interim goodwill impairment analysis that was performed as of November 30, 2012. As a result of the increase in the carrying amount of goodwill resulting from the restatement, in our updated interim impairment assessment step one recoverability test we concluded that the carrying value of the reporting unit that included goodwill exceeded its fair value, resulting in an indication of impairment. Therefore we were required to perform the step two analysis to calculate the impairment. We determined the implied goodwill was less than the carrying value and we recognized an impairment write down of goodwill of $25.9 million for the period ended November 30, 2012 and the year ended February 28, 2013, to reduce the carrying value of goodwill to $35.1 million.
	Accordingly, the financial statements for the year ended February 29, 2012 and unaudited quarterly and year-to-date periods ended August 31, 2011, November 30, 2011, February 29, 2012, May 31, 2012, August 31, 2012 and November 30, 2012 were restated in our Annual Report on Form 10-K for the fiscal year ended February 28, 2013, from amounts previously reported. Net loss, basic and diluted net loss per share, accumulated deficit, and shareholders’ equity were also affected by the restatements. These adjustments are carried forward in subsequent periods. The corrections had no impact on total revenue, operating expense, or operating cash flows.
	The following table summarizes the corrections by financial statement line item for the three and nine months ended November 30, 2012:
		As of and for the Three									As of and for the Nine
		Months ended November 30, 2012									Months ended November 30, 2012
		(unaudited)									(unaudited)
		As previously reported			Restatement adjustments			As			As previously reported			Restatement adjustments			As
								restated									restated
	Balance Sheet
	Goodwill	$	47,484,708		$	(12,424,525	)	$	35,060,183		$	47,484,708		$	(12,424,525	)	$	35,060,183
	Intangible assets, net		30,489,139			(200,000	)		30,289,139			30,489,139			(200,000	)		30,289,139
	Total assets		90,274,094			(12,624,525	)		77,649,569			90,274,094			(12,624,525	)		77,649,569
	Deferred income tax liability		-			3,517,652			3,517,652			-			3,517,652			3,517,652
	Total liabilities		9,097,712			3,517,652			12,615,364			9,097,712			3,517,652			12,615,364
	Accumulated deficit		(87,362,012	)		(16,142,177	)		(103,504,189	)		(87,362,012	)		(16,142,177	)		(103,504,189	)
	Total stockholders' equity		81,176,382			(16,142,177	)		65,034,205			81,176,382			(16,142,177	)		65,034,205
	Total liabilities and stockholders' equity		90,274,094			(12,624,525	)		77,649,569			90,274,094			(12,624,525	)		77,649,569
	Statement of Cash Flows
	Net loss		(4,968,347	)		(28,737,724	)		(33,706,071	)		(14,828,941	)		(26,119,001	)		(40,947,942	)
	Goodwill impairment		-			25,919,000			25,919,000			-			25,919,000			25,919,000
	Impairment of intangible assets		5,849,160			2,818,723			8,667,883			5,849,160			2,818,723			8,667,883
	Statement of Stockholders' Equity
	Accumulated deficit		(87,362,012	)		(16,142,177	)		(103,504,189	)		(87,362,012	)		(16,142,177	)		(103,504,189	)
	Stockholders' equity		81,176,382			(16,142,177	)		65,034,205			81,176,382			(16,142,177	)		65,034,205
	Statement of Operations
	Goodwill impairment		-			25,919,000			25,919,000			-			25,919,000			25,919,000
	Impairment of intangible assets		5,849,160			2,818,723			8,667,883			5,849,160			2,818,723			8,667,883
	Income tax benefit		-			-			-			-			2,618,723			2,618,723
	Net loss		(4,968,347	)		(28,737,724	)		(33,706,071	)		(14,828,941	)		(26,119,001	)		(40,947,942	)
	Basic and diluted net loss per share	$	(0.05	)	$	(0.26	)	$	(0.31	)	$	(0.15	)	$	(0.26	)	$	(0.41	)

STOCKHOLDERS_EQUITY

STOCKHOLDERS' EQUITY	9 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 3. STOCKHOLDERS' EQUITY	'
	On October 4, 2013, we completed a $9.6 million financing transaction with 13 investors. The investors purchased units of our securities at $0.40 per unit. Each unit consisted of 1 share of our common stock and a warrant to purchase 0.3 shares of our common stock. An aggregate of 23,875,000 shares of our common stock and warrants to purchase up to 7,162,500 shares of our common stock were purchased in the financing. The warrants have a five year term and an exercise price of $0.60 per share.
	We also issued to the placement agent, for services rendered in connection with the financing and for previously rendered services, 354,310 shares of common stock, a 10-year warrant to purchase up to 596,875 shares of common stock and a 5-year warrant to purchase up to 106,293 shares of common stock. Both warrants have an exercise price of $0.60 per shares.
	During the nine months ended November 30, 2013, we issued approximately 183,800 shares of common stock to our independent directors for payment of fees pursuant to the Board of Director’s compensation plan, 100,000 shares to a consultant for services, and 500,000 shares to legal counsel for services.

SHAREBASED_PAYMENTS

SHARE-BASED PAYMENTS	9 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 4. SHARE-BASED PAYMENTS	'
	Stock-Based Compensation
	Stock-based compensation cost is measured at the grant date based on the estimated fair value of the award. We use the Black-Scholes option pricing model to estimate the fair value of stock options and warrants. The determination of the fair value of stock-based awards on the date of grant using an option pricing model is affected by our stock price as well as assumptions regarding a number of complex and subjective variables. These variables include our expected stock price volatility over the expected term of the awards, actual and projected employee stock option exercise behaviors, a risk-free interest rate and any expected dividends.
	The following table shows the amount of stock-based compensation expense included in the consolidated statements of operations:
		Three Months Ended						Nine Months Ended
		November 30,						November 30,
		2013			2012			2013			2012
	Selling and marketing	$	263,619		$	379,756		$	854,750		$	1,407,393
	Technology and development		126,652			272,621			635,557			882,591
	General and administrative		95,414			723,725			874,092			2,012,375
	Total stock-based compensation expense	$	485,685		$	1,376,102		$	2,364,399		$	4,302,359
	Stock Option Exchange
	On August 29, 2013, we completed a stock option exchange program. Subject to the terms of our exchange offer filed on August 2, 2013, eligible participants tendered, and we exchanged, 5,460,424 options for 1,261,710 new options affecting 73 employees and 2 independent directors. The new options have an exercise price of $0.42, which was the closing price of our common stock on August 29, 2013. The new options were granted with the same vesting proportions as the tendered options. Of the 1,261,710 new option granted, 846,516, or 67%, were vested on the grant date and 415,194 or 33% will vest over the remaining vesting periods of the original options. The tender offer did not result in the acceleration of vesting of any options. The new options have the same expiration dates as the options exchanged.
	We are required to compare the fair value of the options immediately before and after modification and recognize additional compensation expense to the extent the new options have greater value than the exchanged options they replaced. The fair value of the stock options tendered for exchange and the replacement stock options was estimated on August 29, 2013 using the Black-Scholes option-pricing model with the following assumptions:
		Pre-modification			Post-modification
	Weighted-average exercise price	$	2.4		$	0.42
	Expected term (in years)		3			2
	Weighted-average volatility		70	%		70	%
	Risk-free rate		0.79	%		0.39	%
	Expected dividends		0	%		0	%
	The total fair value of the new options issued to each participant in the exchange did not exceed the fair value of the original options outstanding just prior to the exchange. As such, no compensation expense was recognized as a result of the stock option exchange offer.
	OPTIONS:
	We maintain stock incentive plans for our employees. The 2010 Stock Incentive Plan provides for the grant to employees, officers, directors and consultants of incentive stock options, non-qualified stock options, restricted shares, and other stock based awards to purchase up to an aggregate of 15.0 million shares of our common stock. We have approximately 7.6 million stock options and restricted shares outstanding under this plan as of November 30, 2013.
	We have also issued non-qualified stock options to consultants and vendors for services provided, as well as to directors and employees, including officers.
	The estimated fair values of our stock option awards were determined using the following weighted average assumptions:
		Three Months Ended						Nine Months Ended
		November 30,						November 30,
		2013			2012			2013			2012
	Expected dividends		0	%		0	%		0	%		0	%
	Expected term (in years)		3.5			3.5			2.89			3.5
	Weighted-average volatility		70	%		65	%		70	%		62	%
	Risk-free rate		0.84	%		0.43	%		0.55	%		0.44	%
	The summary of activity for our stock options is presented below:
		Number of options			Weighted Average Exercise Price			Average Remaining Contractual Term (In Years)
	Options outstanding at February 28, 2013		17,373,932		$	2			2.99
	Granted		3,067,262			0.43
	Exercised		-			-
	Cancelled or expired		(5,638,549	)		2.46
	Forfeited		(3,245,757	)		2.21
	Options outstanding at November 30, 2013		11,556,888		$	1.31			2.18
	Options vested and expected to vest at November 30, 2013		11,259,486		$	1.32			2.13
	Options exercisable at November 30, 2013		9,573,847		$	1.47			1.73
	As of November 30, 2013, there was $1.4 million of unrecognized share-based payment expense related to options, which is expected to be recognized over a weighted average period of approximately 2.3 years.
	The aggregate intrinsic value of the exercisable options at November 30, 2013 was approximately $196,100. The aggregate intrinsic value was calculated based on the positive differences between the market value of our common stock on November 30, 2013 of $0.53 per share and the exercise prices of the exercisable options. The exercise prices of options outstanding at November 30, 2013 ranged from $0.25 to $3.90.  The weighted average fair value of options granted was $0.25 per option share for the three months ended November 30, 2013.
	WARRANTS:
	The fair values of our stock warrant awards were estimated using the following weighted average assumptions:
		Three Months Ended						Nine Months Ended
		November 30,						November 30,
		2013			2012			2013			2012
	Expected dividends		0	%		0	%		0	%		0	%
	Expected term (in years)		0			5			5			4.75
	Weighted-average volatility		0	%		65	%		70	%		64	%
	Risk-free rate		0	%		0.62	%		1.06	%		0.59
	The summary of activity for our warrants is presented below:
		Number of Warrants			Weighted Average Exercise Price			Average Remaining Contractual Term (In Years)
	Warrants outstanding at February 28, 2013		19,171,104		$	1.32			3.53
	Granted		8,740,668			0.61
	Exercised		-			-
	Forfeited and expired		(712,361	)		1.8
	Warrants outstanding at November 30, 2013		27,199,411		$	1.06			3.65
	Warrants vested and expected to vest at November 30, 2013		27,199,411		$	1.07			3.64
	Warrants exercisable at November 30, 2013		26,378,577		$	1.07			3.64
	As of November 30, 2013, there was approximately $107,971 of unrecognized share-based payment expense related to warrants, which is expected to be recognized over a weighted average period of approximately 1.9 years.
	The aggregate intrinsic value of the exercisable warrants as of November 30, 2013 was approximately $42,000. The aggregate intrinsic value was calculated based on the positive differences between the market value of our common stock on November 30, 2013 of $0.53 per share and the exercise prices of the exercisable options. The exercise prices of warrants outstanding at November 30, 2013 ranged from $0.39 to $4.00.

NET_LOSS_PER_SHARE

NET LOSS PER SHARE	9 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 5. LOSS PER SHARE	'
	Basic net loss per share is based on the weighted average number of common shares outstanding. Diluted net loss per share is based on the weighted average number of common shares and common share equivalents outstanding. Common share equivalents included in the computation represent shares issuable upon assumed exercise of outstanding stock options and warrants except when the effect of their inclusion would be anti-dilutive. As of November 30, 2013 and 2012, there were potentially dilutive securities consisting of options exercisable to purchase 3.1 million and 2.2 million shares of common stock, respectively, and warrants exercisable to purchase 0.3 million and zero shares of our common stock, respectively. As the inclusion of these outstanding stock options and warrants would be anti-dilutive, they were excluded from the computation of loss per share.  Accordingly, basic net loss per share and diluted net loss per share are identical for each of the periods presented in the accompanying statements of operations.

AQUISITIONS

AQUISITIONS	9 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 6 - AQUISITIONS	'
	Acquisition of GEOS IP Assets: On May 24, 2012, we acquired all of the common stock and all of the preferred stock of GEOS Communications IP Holdings, Inc. pursuant to the Stock Purchase Agreement between Augme and GEOS and other parties. By acquiring the GEOS stock, we acquired five U.S. patents covering Voice over Internet Protocol (“VoIP”) and other mobility inventions. The patents allow us to expand our mobile marketing and mobile advertising technology offerings to include adaptive voice technologies for any mobile environment, VoIP-enabled mobile marketing and advertising, VoIP-enabled e-commerce and VoIP-enabled services and support features within our AD LIFE Platform.
	We determined that the GEOS assets acquired did not constitute a business as defined under ASC Topic 805 on the basis that the GEOS assets were not an integrated set of activities or assets that were capable of being conducted or managed in a manner that would provide economic benefits or return to us. As a result, we accounted for this acquisition as an asset purchase. The total consideration paid has been allocated to the intangible assets acquired based upon their relative fair values at the date of acquisition.
	The fair value of the consideration given for the acquisition of the GEOS stock was $4.2 million, which included $355,000 in cash and $3.8 million in our common stock (1,860,465 shares at a price of $2.05 per share). We are indemnified against certain losses resulting from breaches of any representation, warranty, covenant or agreement of GEOS. In order to secure payment of any loss, the approximate 1.9 million shares of our common stock were held for the benefit of the sellers in escrow for a period of up to 14 months following the closing date of the acquisition. In July 2013, the shares were released from escrow.
	As described in Note 2, we recorded an increase to the carrying value of the patents on our balance sheet of $2.6 million to correct errors related to the income tax provision impacts of differences between the book and tax basis of the acquired assets, and a corresponding income tax benefit on our consolidated statement of operations, due to the reduction in the deferred income tax asset valuation allowance during the quarter ended May 31, 2012.
	Acquisition of Hipcricket, Inc. Assets
	On August 25, 2011, Augme completed its acquisition of the business and substantially all of the assets of Hipcricket, Inc. pursuant to the Amended and Restated Asset Purchase Agreement dated August 25, 2011 between Augme and Hipcricket. We accounted for the acquisition as a business combination. The results of Hipcricket’s operations have been included in our financial statements since the date of the acquisition.
	The estimated fair value of the acquisition consideration was $62.8 million, which included $3.0 million in cash, $35.5 million in our common stock (11,457,359 shares at a price of $3.10), a $1.0 million promissory note, which was subsequently paid off in cash, and $2.0 million of seller tax liabilities, which was paid during the quarter ended May 31, 2012. In addition, the transaction called for a twelve-month earn-out payment to Hipcricket shareholders and employees, which if achieved was estimated to be no less than $15.0 million and as high as $27.5 million. The amount of contingent consideration was based on the amount of revenue recognized in the earn-out period and could be paid in our common stock or a combination of common stock and cash at our discretion, provided that the transaction remained a tax-free reorganization. The contingent consideration recorded at the time of the acquisition was $23.3 million plus the seller tax liabilities of $2.0 million, resulting in an aggregate liability on the transaction date of $25.2 million. The tax liability of $2.0 million was paid during the quarter ended May 31, 2012.
	The earn-out period ended on August 25, 2012, which was the measurement date of the contingent consideration obligation. The earn-out payment was calculated to be $22.0 million and we recognized a gain of $2.0 million from the reduction of the liability of the actual consideration due, compared to management’s previous estimates. The gain is included within other income on the statements of operations for the nine months ended November 30, 2012.
	As partial satisfaction of the contingent consideration payments, we paid approximately 50% of the outstanding obligation using shares of our common stock. We issued a total of 5.5 million shares of our common stock as payment of approximately $11.0 million in contingent consideration to the former Hipcricket stockholders. The number of common shares issued was calculated using a $2.00 per share “floor” price, as defined in the agreement. The market price of our common stock on August 25, 2012 was $1.48.  The difference between the $2.00 floor price used to calculate the number of shares to be issued, and the actual price of $1.48 on the measurement date, resulted in a reduction of the estimated consideration payment of $2.9 million, which is included in other income on the statements of operations for the nine months ended November 30, 2012.
	On November 2, 2012 we issued 3.7 million shares of common stock, net of tax withholding, for substantially all of the remaining contingent consideration obligation. On December 4, 2012, this amount was reduced by 27,322 shares. The difference between the $2.00 floor price and the actual price of $0.65 on the date the shares were issued resulted in a reduction of the estimated contingent consideration payment of $7.3 million, which was included in other income on the statements of operations for the three and nine months ended November 30, 2012.

INTANGIBLE_ASSETS

INTANGIBLE ASSETS	9 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 7 - INTANGIBLE ASSETS	'
	In the fiscal quarter ended November 30, 2012, we entered into negotiations with a potential buyer for the sale of certain of our assets including certain GEOS and Jagtag IP patents. We reached a conclusion that these patent assets met all of the criteria to be held for sale and had an estimated value of $3.5 million. We estimated the fair value of the patents by calculating the expected proceeds to be received through a sale, exclusive license agreement and royalties that would have been paid to a third party had we not owned the patents. We applied a discounted cash flow model based on certain scenarios, but significantly weighted towards outright sale given our intent to dispose or exclusively license the rights to these patents. In estimating the fair value of these patents, we used our own assumptions about the use of the patents by a market participant and considered all available evidence. We classified these intangible assets as held for sale as of November 30, 2012.  In March 2013, we closed a transaction with the buyer which did not include sale of the GEOS and Jagtag IP patents. As part of our September 2012 restructuring plan, we planned to sell these patents as a stated means of deriving value from the assets. At that time, we concluded that it was probable that we would continue to market the patents for sale and that it was likely such a sale would be completed within one year. In the quarter ended November 30, 2013, we discontinued efforts to actively market these patents for sale. Consequently, we have reclassified these intangible assets from “held for sale” to “held and used.” In estimating the fair value of the patents upon transfer to held and used, we evaluated current industry trends for the types of technology covered or enabled by these patents and used our own assumptions about the use of the patents by market participants. For the quarter ended November 30, 2013, we reclassified $3.12 million from Intangible Assets Held for Sale to Held and Used, and recognized a $376,984 charge upon reclassification equal to the estimated depreciation expense that would have been attributed to the assets if they had been continuously held and used for the past year.
	As described in Note 8 of the consolidated financial statements, during the quarter ended November 30, 2013 we settled our litigation case with Millennial Media, Inc. and wrote down capitalized costs related to this case, resulting in an impairment charge of $87,975.
	The following table presents the gross carrying value of the components of intangible assets and accumulated amortization:
				As of November 30, 2013
		Weighted Average Amortization Period (In months)		Carrying Amount, net of impairment write downs		Accumulated Amortization		Transferred from Held For Sale		Impairment Loss		Net Carrying Value
	Indefinite Lived Intangible:
	Trade name	Indefinite		$	8,700,000	$	-	$	-	$	-	$	8,700,000
	Definite Lived Intangible:
	Patent litigation		84		4,350,749		1,733,508		-		87,975		2,529,266
	Patents		120		717,846		107,415		3,123,016		-		3,733,447
	Acquired technology		60		7,270,000		3,556,250		-		-		3,713,750
	Customer relationships		60-72		12,850,000		6,047,708		-		-		6,802,292
	Software		36		2,095,705		2,095,705		-		-		-
	Non-compete agreements		36		212,000		212,000		-		-		-
	Trade names		24		44,000		44,000		-		-		-
	Total intangibles			$	36,240,300	$	13,796,586	$	3,123,016	$	87,975	$	25,478,755
				As of February 28, 2013
		Weighted Average Amortization Period (In months)		Carrying Amount, net of impairment write downs		Accumulated Amortization		Transfer to Held for Sale		Net Carrying Value
	Indefinite Lived Intangible:
	Trade name	Indefinite		$	8,700,000	$	-	$	-	$	8,700,000
	Definite Lived Intangible:
	Patent litigation		84		4,038,904		1,060,109		-		2,978,795
	Patents		120		4,174,306		51,356		3,500,000		622,950
	Acquired technology		60		7,270,000		2,465,750		-		4,804,250
	Customer relationships		60-72		12,850,000		4,143,958		-		8,706,042
	Software		36		2,095,705		2,095,705		-		-
	Non-compete agreements		36		212,000		212,000		-		-
	Trade names		24		44,000		44,000		-		-
	Total intangibles			$	39,384,915	$	10,072,878	$	3,500,000	$	25,812,037
	Intangible assets relate to patent filing and patent protection litigation costs as well as customer relationships, trade names and technology obtained in past acquisitions. With the exception of the Hipcricket trade name carried at $8.7 million, the intangible assets have finite lives and, as such, are subject to amortization. Amortization of intangible assets was $1.3 million and $3.8 million, for the three and nine months ended November 30, 2013, respectively.
	Amortization in future fiscal periods is expected to be as follows:
	Remainder of 2014	$	1,338,436
	2015		5,269,995
	2016		4,982,069
	2017		2,910,246
	2018		447,827
	Thereafter		1,830,182
	Total	$	16,778,755

CONTINGENCIES

CONTINGENCIES	9 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 8. CONTINGENCIES	'
	Litigation
	In the normal course of business, we may become involved in various legal proceedings.  Except as stated below, we know of no pending or threatened legal proceeding to which we are or will be a party that, if successful, might result in a material adverse change in our business, properties or financial condition.
	Litigation Update
	Augme Technologies, Inc. v. Yahoo! Inc., Civil Action No. 3:09-cv-05386-JCS, a patent infringement lawsuit pending in the U.S. District Court for the Northern District of California since November 16, 2009. On December 21, 2010, Yahoo! filed a first amended answer to Augme’s complaint, in which Yahoo! asserted its own counterclaim against Augme alleging infringement of, inter alia, U.S. Patent Nos. 7,640,320 (“‘320 patent”) and 7,512,622 (“‘622 patent”). On August 21, 2012, the parties stipulated to dismissal of Yahoo’s claim for infringement of the ‘622 patent with prejudice.
	This case is a patent infringement lawsuit brought by Augme against Yahoo, Inc. Yahoo has also counterclaimed for patent infringement. In this case, Augme is seeking monetary relief for patent infringement damage and injunctive relief against future infringement. A summary of the case is set forth below.
	With respect to Augme’s claims of patent infringement, on June 11, 2012, Yahoo! renewed its Motion for Summary Judgment of non-infringement. The Court heard argument on the summary judgment issues on July 20, 2012. On August 8, 2012, the Court granted Yahoo!’s Motion for Summary Judgment of non-infringement, dismissing Augme’s patent claims against Yahoo! and declining to address Augme’s previously filed Motion for Partial Summary Judgment of validity. Based on the Court’s summary judgment order, Augme moved for Entry of Judgment under Rule 54(b). Yahoo! opposed Augme’s motion in light of the pending counterclaim for infringement of the ‘320 patent. Nonetheless, Augme’s motion was granted by the Court on October 29, 2012, and final judgment was entered shortly thereafter on November 15, 2012. On December 12, 2012, Augme filed a Notice of Appeal as to the judgment as to the Augme patent. The appeal was docketed by the Federal Circuit on December 19, 2012.
	With respect to Yahoo!’s counterclaim regarding infringement of the ‘320 patent, the parties agreed to and filed a stipulation of infringement of this patent on December 13, 2012, under the Court’s claim construction ruling of January 3, 2012.  The parties also stipulated to entry of judgment under Rule 54(b) and 28 U.S.C. § 1292(c)(2), which permits the entry of judgment in patent cases “which … [are] final except for an accounting.” The parties also requested that the Court stay the remainder of the case pending Augme’s appeal to the Federal Circuit Court of Appeals. The Court signed such an order on December 13, 2012, and entered it the next day.
	On January 11, 2013, Augme filed with the district court a Notice of Appeal to the Federal Circuit Court of Appeals as to Yahoo!’s ‘320 patent judgment. The second appeal was docketed by the Federal Circuit on February 6, 2013 and consolidated with the prior appeal (now Lead Appeal No. 13-1121). Augme tendered its principal brief to the Federal Circuit on May 7, 2013. Augme filed its Reply Brief on September 6, 2013, and the parties subsequently filed a Joint Appendix on September 13, 2013. Both consolidated appeals remain pending before the Federal Circuit.
	Augme Technologies, Inc. v. Millennial Media, Inc., Civil Action No. 1:12-cv-00424, a patent infringement lawsuit pending in the U.S. District Court for the District of Delaware since April 5, 2012. Augme filed a case against Millennial Media, Inc., asserting three causes of action involving alleged patent infringement related to Augme-owned United States Patent No. 7,783,721, United States Patent No. 7,269,636 and United States Patent No. 6,594,691.
	This case is a patent infringement lawsuit filed by Augme against Millennial Media, Inc. As originally filed, Augme was seeking monetary relief for patent infringement damage and injunctive relief against future infringement. A summary of the current status is set forth below.
	On May 30, 2012, Millennial Media filed a Motion to Dismiss For Failure to State a Claim Under Federal Rule of Civil Procedure 12(b)(6). Augme filed an amended complaint and an answer brief on June 18, 2012, and Millennial Media withdrew its Motion to Dismiss on June 28, 2012. A Scheduling Order was entered on September 28, 2012. The case was set for a seven day jury trial beginning on September 15, 2014. On March 22, 2013, the parties began settlement discussions. To facilitate those discussions, the parties filed, on April 12, 2013, a stipulation to stay further proceeding in the case which Judge Stark entered as an order on April 18, 2013. As required by the joint stipulation, the parties filed a joint status report on July 1, 2013, stipulated that the stay be continued at least until October 1, 2013. On September 30, 2013, the parties filed a joint status report requesting that the stay be continued at least until December 1. However, on November 29, 2013, the parties agreed to settle the litigation and filed a Stipulation and Proposed Order of Dismissal on December 2, 2013. Pursuant to the settlement, the parties agreed to dismiss the lawsuit with each side to bear its own costs, and to dispose of the various claims they had asserted against each other.
	Augme Technologies, Inc. v. AOL, Inc. and Time Warner, Inc., Civil Action No. 1:12-cv-05439-CM (transferred from Civil Action No. 1:09-cv-04299-RWS (S.D.N.Y.)), a patent infringement and trademark infringement lawsuit pending in the U.S. District Court for the Southern District of New York (transferred from the U.S. District Court for the Central District of California) since September 10, 2008.
	The case is a patent infringement case originally filed by Augme against AOL, Inc. and Time Warner, Inc. in the Central District of California and subsequently transferred to the Southern District of New York.  It also originally included a trademark infringement action against AOL, Inc. for use of the BOOMBOX trademark which has subsequently been dismissed.  In its patent infringement claim, Augme sought both monetary relief for patent infringement damages and injunctive relief against further infringement by AOL and Time Warner.  The AOL defendants and Augme agreed to settle litigation between themselves and, on February 26, 2013, the case was dismissed between those parties. The stayed case remains pending against Time Warner, Inc.  Below is a summary of the current status of this case.
	On June 13, 2012, the patent infringement claims were transferred from Judge Robert Sweet to Judge Colleen McMahon.  The residual claims for trademark infringement, unfair competition and false designation of origin, which remained with Judge Sweet, were dismissed by agreement of the parties on November 19, 2012.
	With regard to the patent infringement claims, Time Warner filed a Motion for Judgment on the Pleadings on September 27, 2012, and, shortly thereafter, a Motion for Rule 11 Sanctions on October 23, 2012.  On October 26, 2012, the Court sua sponte stayed the case regarding any claims related to U.S. Patent No. 7,269,636 (“‘636 patent”), pending the outcome of the ongoing reexamination of that patent by the U.S. Patent and Trademark Office.  Because the remaining patent-in-suit, U.S. Patent Nos. 6,594,691 (“‘691 patent”), is closely related to the ‘636 patent, Augme moved to stay the case in its entirety on November 5, 2012.  On December 20, 2012, Judge McMahon denied Augme’s motion to stay as to the ‘691 patent and did not disturb the preexisting stay as to the ‘636 patent.
	Because of Judge McMahon’s requirement that all discovery in the case be completed by the end of February 2013 and given that discovery as to the ‘691 patent would be totally duplicative of discovery which would have to be conducted later as to the ‘636 patent, on January 7, 2013, Augme filed a covenant not to sue defendants on the ‘691 patent and a motion to dismiss the ‘691 patent from the case.  Based on the pendency of the motion to dismiss, on January 11, 2013, Magistrate Judge Gabriel Gorenstein adjourned all further discovery as to the ‘691 patent.
	On January 16, 2013, Judge McMahon entered an order dismissing the ‘691 patent from the case and maintaining the stay as to the ‘636 patent. She placed the case on suspension and denied Time Warner’s pending motions without prejudice.
	The AOL defendants and Augme agreed to settle the litigation as between Augme, on the one hand, and AOL, Inc. and AOL Advertising, Inc., on the other. Accordingly, on February 26, 2013, Judge McMahon entered an Order of Dismissal as to the parties, AOL, Inc. and AOL Advertising, Inc. The stayed case remains pending against Time Warner, Inc.
	On July 16, 2013, the court denied Time Warner’s motion for sanctions against Augme without prejudice to renewal, pending the outcome of the USPTO reexamination.
	Brandofino Communications vs. Augme Technologies, Inc.  Civil Action No. 652639/2011. On September 27, 2011, Brandofino Communications, Inc. (“Brandofino”) filed suit against Augme and New Aug LLC in the Supreme Court of the State of New York, New York County.  The complaint alleges, inter alia, breach of contract and unjust enrichment claims arising from work Brandofino allegedly performed for Augme pursuant to a marketing agreement entered into by Brandofino and Augme.  Augme has served its Answer and set forth counterclaims for breach of contract, unfair competition, tortious interference with business relations, and violations of New York General Business Law Section 349 (relating to violations of Augme’s intellectual property rights). The Company intends to vigorously defend against Brandofino’s claim and pursue its counterclaims.
	Shaub & Williams, L.L.P., vs. Augme Technologies, Inc., Civil Action No. 1:13-cv-01101-GBD. Augme's prior counsel, Shaub & Williams, LLP, filed a Complaint in the United States District Court for the Southern District of New York seeking recovery on a quantum meruit (value of services) basis attorney's fees in the amount of $2,249,686.25 for its prior representation of Augme in litigation. Augme filed and served (1) an Answer denying the material allegations and claims of the First Amended Complaint; (2) counterclaims for professional negligence and breach of contract. Shaub & Williams filed motions to dismiss Augme's counterclaims and to strike certain of Augme's affirmative defenses to the complaint, in addition to an early motion for summary judgment seeking to dismiss Augme's counterclaims. The Court denied the motion for summary judgment, but at hearing October 7 on the motion to dismiss indicated that Augme's affirmative counterclaims may have insufficient factual support. Augme was given leave to submit a proposed amended Counterclaim by October 21.The Court subsequently indicated the affirmative defenses are sufficient. A further status conference has been set for January 14, 2014, at which time the Court will finalize a trial date. In the meantime, the parties are conducting discovery on the claims and counterclaims.
	Leibsohn et al vs. Hipcricket, Inc. (FKA Augme Technologies, Inc.), Civil Action No. 13-2-40007-3. On November 26, 2013, shareholders of the former Hipcricket, Inc., who were shareholders at the time of Augme’s acquisition of Hipcricket, filed suit in Superior Court of Washington for King County, alleging Augme’s management and directors at the time of the merger intentionally and negligently misrepresented facts related to the expected growth of the acquiring company, which resulted in shareholder approval of the merger and subsequent loss of value related to the combined entity. The Plaintiff’s also allege violations of the Washington State Securities Act and seek compensatory and punitive damages, interest, attorneys and other fees. The Company intends to vigorously defend against the plaintiffs’ claims and cannot at this time estimate any potential loss given the recent timing of the case brought against the parties.

LINE_OF_CREDIT

LINE OF CREDIT	9 Months Ended
	Nov. 30, 2013
Debt Disclosure [Abstract]	'
Note 9. LINE OF CREDIT	'
	On May 21, 2013, we entered into a loan and security agreement with Silicon Valley Bank (“SVB”), which was amended and restated on November 25, 2013.  The agreement, as amended and restated, provides for a $5.0 million asset based revolving loan facility, with availability subject to a borrowing base of 90% of our eligible accounts receivable, decreasing to 80% of eligible accounts receivable plus the least of (i) 80% of Eligible 120 Day Accounts as defined in the Agreement, (ii) One Million Dollars ($1,000,000), and (iii) 30% of the sum of all eligible accounts plus Eligible 120 Day Accounts after December 31, 2013, and the satisfaction of conditions specified in the agreement. The facility expires on May 3, 2015, at which time all outstanding amounts will become due and payable.
	Amounts drawn under the facility accrue interest at a floating per annum rate equal to 1.25% above the prime rate, or 0.75% above prime rate at all times when a Streamline Period is in effect. A Streamline Period commences on the first day of the month following the day that we provide SVB a written notice that, for each consecutive day in the immediately preceding fiscal quarter, we had unrestricted cash at Silicon Valley Bank plus the unused amount available under the facility in an amount above $4.0 million, subject to terms and conditions of the loan agreement. Interest is payable monthly. We also are required to pay SVB a quarterly fee equal to 0.25% per annum of the average unused portion of the facility. The facility is secured by substantially all of our assets. Borrowings under the facility may be used for general corporate purposes, including funding working capital. As of the November 301, 2013, we had drawn $1.4 million from the line of credit and had approximately $3.2 million available based on our outstanding accounts receivable as of that date.
	The loan agreement includes customary covenants, including covenants that limit or restrict our ability to, without the prior written consent of SVB, dispose of assets, change our business, have a change in control, make acquisitions, be acquired, incur indebtedness, grant liens, make investments, make distributions, repurchase stock, and enter into certain transactions with affiliates. The loan agreement also requires us to maintain a minimum tangible net worth of at least negative $1.25 million, increasing (i) at the end of each month by 50% of the proceeds of issuances of equity securities and the principal amount of any subordinated debt received during such month, (ii) at the end of each calendar quarter 50% of net income for such quarter and (iii) immediately by 1.5x the cash received by us from the sale of any intellectual property minus any realized gain or plus any realized loss associated with the sale of such intellectual property.
	The loan agreement contains customary events of default that include non-payment defaults, covenant defaults, material adverse change defaults, insolvency defaults, material judgment defaults and inaccuracy of representations and warranty defaults. The occurrence of an event of default could result in the acceleration of obligations under the loan agreement, in which case we must repay all loans and related charges, fees and amounts then due and payable. At the election of SVB, upon the occurrence and during the continuance of an event of default, the interest rate will increase an additional 5.0% per annum above the rate that is otherwise applicable.
	We are required to deliver periodic reports to SVB regarding our ability to meet certain financial and other covenants contained in the loan agreement. In late July we delivered the report to SVB indicating that as of June 30, 2013, we had breached our minimum tangible net worth covenant and began discussions of a forbearance agreement with SVB. On November 25, 2013, we entered into an amended and restated loan and security agreement with SVB. The amended and restated agreement retained substantially the same terms as the original loan and security agreement, except the borrowing base was amended as described above and the collateral securing the loan facility was expanded to include our intellectual property. In connection with the execution of the amended and restated agreement, we obtained a waiver of the covenant default.

CONCENTRATION_OF_RISK

CONCENTRATION OF RISK	9 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 10. CONCENTRATION OF RISK	'
	During the quarter ended November 30, 2013, two customers accounted for approximately 7% and 6% of our revenue and no other customer accounted for over 5% of revenues.  During the quarter ended November 30, 2012, three customers  accounted for approximately 9%, 6%, and 5% of our revenue and no other customer accounted for over 5% of revenue.
	During the nine months ended November 30, 2013, two customers accounted for approximately 6% and 5% of our revenue and no other customer accounted for over 5% of our revenues.  During the nine months ended November 30, 2012, two customers accounted for approximately 10% and 7% of our revenue and not other customer accounted for over 5% of revenues.
	At November 30, 2013, three customers accounted for approximately 25% of accounts receivable, the largest of which accounted for 11%. At November 30, 2012, three customers accounted for 29% of accounts receivable, the largest of which accounted for approximately 12%.

ORGANIZATION_AND_BASIS_OF_PRES1

ORGANIZATION AND BASIS OF PRESENTATION (Policies)	9 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Organization and Basis of Presentation and Description of Business	'
	The accompanying unaudited interim financial statements of Hipcricket, Inc. (“Hipcricket,” the “Company,” “we,” or “us”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”), and should be read in conjunction with the audited financial statements and notes thereto contained in our Annual Report on Form 10-K filed with the SEC on May 24, 2013.
	In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosures contained in the audited financial statements for the fiscal year ended February 28, 2013 included in our Annual Report on Form 10-K have been omitted.
	Description of Business
	On August 23, 2013, we changed our company name from Augme Technologies, Inc. to Hipcricket, Inc. Hipcricket®, Augme®, Augme Technologies™, AD LIFE® (“AD LIFE”), AD SERVE®, A+®, Boombox® and the Company logos are trademarks of Hipcricket, Inc.
	We provide mobile advertising and mobile marketing technology and services that empower brands, agencies and media companies to engage customers, drive loyalty and increase sales. Our proprietary software-as-a-service AD LIFE platform (the “Platform”) allows marketers, brands, and agencies to plan, create, test, deploy, and track mobile marketing programs across nearly every mobile channel. Through the use of Consumer Response Tags such as 2D codes, UPC codes, short message service, and image recognition, our Platform facilitates consumer brand interaction and the ability to track and analyze campaign results. Using our patented device-detection and proprietary mobile content adaptation software, AD LIFE solves the mobile marketing industry problem of disparate operating systems, device types, and on-screen mobile content rendering. We also provide business-to-consumer utilities including national mobile couponing solutions, strategic mobile healthcare tools, custom mobile application development and consumer data tracking and analytics. Our products serve advertisers and ad agencies in many vertical markets, including automotive, retail, consumer products, food and beverage, media and broadcast, pharmaceutical and restaurant brands.
	The mobile marketing and advertising landscape, while in its early stages, is highly competitive. Many of the landscape’s significant players are focused on delivering point solutions targeting a specific segment of the mobile marketing and/or advertising landscape.  We differ from the competition by offering complete, end-to-end mobile advertising and marketing solutions delivered through our AD LIFE Platform.
	Our advanced, comprehensive, and fully integrated Platform drives revenue primarily through license fees, marketing campaign fees, and fees associated with certain add-on promotional applications in the Platform. Additional revenue is generated by platform administration and professional service fees related to the mobilization of client content and implementation of marketing campaigns through the Platform.
	Our portfolio of patents covers technical processes and methods that are believed to be a foundational component of behavioral targeting — the automatic provision of customized content to individuals based on information such as past web activity, personal preferences, geography, or demographic data. As of November 30, 2013 we owned 21 U.S. patents. We are pursuing on a selective basis, additional patents that generally relate to targeting, analytics, advanced mobile marketing, customized content delivery, and mobile and networked marketing technology.
	We operate under one reportable segment. In December 2013, we relocated our corporate headquarters to 110 110th Avenue NE, Suite 410, Bellevue, Washington 98004. Additionally, we maintain a presence in New York, Atlanta, Miami, Dallas, Chicago, San Francisco and Los Angeles.
Liquidity	'
	Liquidity
	As of November 30, 2013 and February 28, 2013, we had accumulated deficits of $126.1 million and $111.4 million, respectively. We are subject to the risks and challenges associated with companies at a similar stage of development including dependence on key individuals, successful development and marketing of our products and services, integration of recent business combinations, competition from alternative products and services and larger companies with greater financial, technical management and marketing resources. Further, we may require additional financing to execute our key business strategies and fund operations. Those funds may not be readily available or may not be on terms that are favorable to us. Certain financing terms could be dilutive to existing shareholders or could result in significant interest or other costs, or require us to license or relinquish certain intellectual property rights.
	We operate in the mobile marketing industry and, accordingly, can be affected by a variety of factors. For example, we believe that any of the following factors could have a significant negative effect on our future financial position, results of operations and cash flows: unanticipated fluctuations in quarterly operating results, adverse changes in our relationship with significant customers or failure to secure contracts with other customers, intense competition, failure to attract and retain key personnel, failure to protect  intellectual property, decrease in the migration trends from traditional advertising methods to digital and mobile media and the inability to manage growth.
	In September 2012, we adopted a restructuring plan which included reducing the number of employees, slowing the pace of investments in our intellectual property (“IP”) portfolio and minimizing variable expenses. We have restructured overall corporate overhead expenses in order to focus our business around our mobile marketing and advertising technology and services. Consistent with this plan, we have settled a majority of our patent litigation cases, while protecting the value of our IP assets, to reduce our ongoing legal costs, downsized our Tucson division which was primarily involved with development and monetization of our IP, streamlined personnel and variable costs, and solidified the management team by appointing new personnel with extensive experience in the mobile marketing and advertising space to lead our sales and engineering teams. We have made substantial improvements in lowering our operating expenses, compared to the same period one year ago. We intend to continue our efforts to minimize cash spend and identify additional cost savings opportunities while carefully investing our resources and protecting our strategic assets to strengthen our position in the mobile marketing and mobile advertising industry.
	During the quarter ended May 31, 2013, we secured an accounts receivable credit facility from Silicon Valley Bank (“SVB”) to help fund our working capital needs, which was amended and restated on November 25, 2013. The revolving loan facility has a two-year term and allows us to borrow up to $5.0 million based upon a formula equal to 90% of eligible accounts receivable, decreasing to 80% of eligible accounts receivable plus the least of (i) 80% of Eligible 120 Day Accounts as defined in the amended and restated loan agreement (the “Amended Agreement”), (ii) $1,000,000, and (iii) 30% of the sum of all eligible accounts plus Eligible 120 Day Accounts after December 31, 2013. The facility is secured by substantially all of our assets. Amounts drawn under the facility accrue annual interest at the prime rate plus 0.75% during a Streamline Period, as defined in the Amended Agreement, and at the prime rate plus 1.25% when a Streamline Period is not in effect. We are required to deliver periodic reports to SVB regarding our ability to meet certain financial and other covenants contained in the loan Amended Agreement. In late July we delivered the report to SVB indicating that as of June 30, 2013, we had breached our minimum tangible net worth covenant and began discussions of a forbearance or waiver agreement with SVB. On November 25, 2013, we entered into the Amended Agreement with SVB. The Amended Agreement retained substantially the same terms as the original loan and security agreement, except the borrowing base was amended as described above and the collateral securing the loan facility was expanded to include our intellectual property. In connection with the execution of the Agreement, we obtained a waiver of our covenant default. As of the November 30, 2013, we had drawn $1.4 million from this line of credit and had approximately $3.2 million available based on our outstanding accounts receivable as of that date. See Note 9 below for additional information about the credit facility.
	On October 4, 2013, we closed a $9.6 million financing transaction with 13 investors, each of which is an “accredited investor” within the meaning of the Securities Act of 1933. The investors purchased units of our securities at $0.40 per unit.  We received net proceeds of $9.0 million, reflecting approximately $581,000 in fees and costs associated with the financing. Each unit consisted of one share of our common stock and a warrant to purchase 0.3 shares of our common stock. An aggregate of 23,875,000 shares of our common stock and warrants to purchase up to 7,162,500 shares of our common stock were purchased in the financing. The warrants have a five year term and an exercise price of $0.60 per share. In connection with the financing, we also entered into a registration rights agreement with each investor pursuant to which we have agreed to file and maintain effectiveness of a registration statement covering the resale of all of the shares of common stock and shares of common stock underlying the warrants sold in the financing. We filed a registration statement on Form S-1 with the SEC on November 4, 2013. The registration statement was declared effective on November 8, 2013.
	In the future, we may need to raise additional cash through equity or debt financings, and/or sell all or part of our patent portfolio, while retaining the rights to use the patents in our technology. There is no certainty that we will have the ability to raise additional funds through debt or equity financings under terms acceptable to us or that we will have the ability to sell all or part of the patent portfolio. If sources of capital are unavailable, or are available only on a limited basis or under unacceptable terms, then we could be required to substantially reduce or discontinue our investments in new customers and new products; reduce selling, marketing, general and administrative costs related to our continuing operations; or limit the scope of our continuing operations. Due to the nature of our operations and financial commitments we may not have the discretion to reduce operations in an orderly manner to a more sustainable level without impacting future operations.
	As of the filing of our Annual Report on Form 10-K for the fiscal year ended February 28, 2013, we no longer met the minimum $75 million public float requirement for use of Form S-3 registration for primary sales of our common stock and therefore are limited in our ability to issue the remaining $41.4 million remaining on our existing Form S-3 and/or to file new shelf registration statements on Form S-3. Until such time as we satisfy the $75 million public float and other requirements for use of Form S-3 registration, we will be required to use a registration statement on Form S-1 to register securities with the SEC or issue such securities in a private placement, which could increase the cost of raising capital.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the amounts reported in the financial statements. We regularly evaluate estimates and judgments based on historical experience and other relevant facts and circumstances. Actual results could differ from those estimates. Significant estimates relate to fair value of assets acquired and liabilities assumed in business combinations, acquisition related contingent consideration, allowances for tax assets, the use of the Black-Scholes pricing model for valuing stock option and common stock warrant issuances, estimates of future cash flows used to evaluate impairment of long-lived assets, revenues earned from percentage of completion contracts and the period in which revenues should be recorded.
Reclassifications	'
	Reclassifications
	Certain reclassifications have been made to prior periods to conform to current reporting. The presentation of our Consolidated Statements of Operations has been adjusted for the reclassification of operating expenses to be presented in the following categories: sales and marketing, technology and development, general and administrative and depreciation and amortization.  The operating expenses for the three and nine months ended November 30, 2012 have been reclassified accordingly.
Summary of Significant Accounting Policies	'
	Summary of Significant Accounting Policies
	The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and pursuant to the rules and regulations of the SEC. The same accounting policies are followed for preparing the quarterly and annual financial information unless otherwise disclosed.

RESTATEMENT_OF_PREVIOUSLY_ISSU1

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)	9 Months Ended
	Nov. 30, 2013
Restatement Of Previously Issued Financial Statements Tables	'
Restatement	'
		As of and for the Three									As of and for the Nine
		Months ended November 30, 2012									Months ended November 30, 2012
		(unaudited)									(unaudited)
		As previously reported			Restatement adjustments			As			As previously reported			Restatement adjustments			As
								restated									restated
	Balance Sheet
	Goodwill	$	47,484,708		$	(12,424,525	)	$	35,060,183		$	47,484,708		$	(12,424,525	)	$	35,060,183
	Intangible assets, net		30,489,139			(200,000	)		30,289,139			30,489,139			(200,000	)		30,289,139
	Total assets		90,274,094			(12,624,525	)		77,649,569			90,274,094			(12,624,525	)		77,649,569
	Deferred income tax liability		-			3,517,652			3,517,652			-			3,517,652			3,517,652
	Total liabilities		9,097,712			3,517,652			12,615,364			9,097,712			3,517,652			12,615,364
	Accumulated deficit		(87,362,012	)		(16,142,177	)		(103,504,189	)		(87,362,012	)		(16,142,177	)		(103,504,189	)
	Total stockholders' equity		81,176,382			(16,142,177	)		65,034,205			81,176,382			(16,142,177	)		65,034,205
	Total liabilities and stockholders' equity		90,274,094			(12,624,525	)		77,649,569			90,274,094			(12,624,525	)		77,649,569
	Statement of Cash Flows
	Net loss		(4,968,347	)		(28,737,724	)		(33,706,071	)		(14,828,941	)		(26,119,001	)		(40,947,942	)
	Goodwill impairment		-			25,919,000			25,919,000			-			25,919,000			25,919,000
	Impairment of intangible assets		5,849,160			2,818,723			8,667,883			5,849,160			2,818,723			8,667,883
	Statement of Stockholders' Equity
	Accumulated deficit		(87,362,012	)		(16,142,177	)		(103,504,189	)		(87,362,012	)		(16,142,177	)		(103,504,189	)
	Stockholders' equity		81,176,382			(16,142,177	)		65,034,205			81,176,382			(16,142,177	)		65,034,205
	Statement of Operations
	Goodwill impairment		-			25,919,000			25,919,000			-			25,919,000			25,919,000
	Impairment of intangible assets		5,849,160			2,818,723			8,667,883			5,849,160			2,818,723			8,667,883
	Income tax benefit		-			-			-			-			2,618,723			2,618,723
	Net loss		(4,968,347	)		(28,737,724	)		(33,706,071	)		(14,828,941	)		(26,119,001	)		(40,947,942	)
	Basic and diluted net loss per share	$	(0.05	)	$	(0.26	)	$	(0.31	)	$	(0.15	)	$	(0.26	)	$	(0.41	)

SHAREBASED_PAYMENT_Tables

SHARE-BASED PAYMENT (Tables)	9 Months Ended
	Nov. 30, 2013
Stock-based compensation expense included in statement of operations	'
		Three Months Ended						Nine Months Ended
		November 30,						November 30,
		2013			2012			2013			2012
	Selling and marketing	$	263,619		$	379,756		$	854,750		$	1,407,393
	Technology and development		126,652			272,621			635,557			882,591
	General and administrative		95,414			723,725			874,092			2,012,375
	Total stock-based compensation expense	$	485,685		$	1,376,102		$	2,364,399		$	4,302,359
Fair value assumptions of share-based payment award	'
		Three Months Ended						Nine Months Ended
		November 30,						November 30,
		2013			2012			2013			2012
	Expected dividends		0	%		0	%		0	%		0	%
	Expected term (in years)		3.5			3.5			2.89			3.5
	Weighted-average volatility		70	%		65	%		70	%		62	%
	Risk-free rate		0.84	%		0.43	%		0.55	%		0.44	%
Summary of activity of share-based payment award	'
		Number of options			Weighted Average Exercise Price			Average Remaining Contractual Term (In Years)
	Options outstanding at February 28, 2013		17,373,932		$	2			2.99
	Granted		3,067,262			0.43
	Exercised		-			-
	Cancelled or expired		(5,638,549	)		2.46
	Forfeited		(3,245,757	)		2.21
	Options outstanding at November 30, 2013		11,556,888		$	1.31			2.18
	Options vested and expected to vest at November 30, 2013		11,259,486		$	1.32			2.13
	Options exercisable at November 30, 2013		9,573,847		$	1.47			1.73
Option Exchange [Member]	'
Fair value assumptions of share-based payment award	'
		Pre-modification			Post-modification
	Weighted-average exercise price	$	2.4		$	0.42
	Expected term (in years)		3			2
	Weighted-average volatility		70	%		70	%
	Risk-free rate		0.79	%		0.39	%
	Expected dividends		0	%		0	%
Warrant [Member]	'
Fair value assumptions of share-based payment award	'
		Three Months Ended						Nine Months Ended
		November 30,						November 30,
		2013			2012			2013			2012
	Expected dividends		0	%		0	%		0	%		0	%
	Expected term (in years)		0			5			5			4.75
	Weighted-average volatility		0	%		65	%		70	%		64	%
	Risk-free rate		0	%		0.62	%		1.06	%		0.59
Summary of activity of share-based payment award	'
		Number of Warrants			Weighted Average Exercise Price			Average Remaining Contractual Term (In Years)
	Warrants outstanding at February 28, 2013		19,171,104		$	1.32			3.53
	Granted		8,740,668			0.61
	Exercised		-			-
	Forfeited and expired		(712,361	)		1.8
	Warrants outstanding at November 30, 2013		27,199,411		$	1.06			3.65
	Warrants vested and expected to vest at November 30, 2013		27,199,411		$	1.07			3.64
	Warrants exercisable at November 30, 2013		26,378,577		$	1.07			3.64

INTANGIBLE_ASSETS_Tables

INTANGIBLE ASSETS (Tables)	9 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Gross carrying value of intangible assets and accumulated amortization	'
				As of November 30, 2013
		Weighted Average Amortization Period (In months)		Carrying Amount, net of impairment write downs		Accumulated Amortization		Transferred from Held For Sale		Impairment Loss		Net Carrying Value
	Indefinite Lived Intangible:
	Trade name	Indefinite		$	8,700,000	$	-	$	-	$	-	$	8,700,000
	Definite Lived Intangible:
	Patent litigation		84		4,350,749		1,733,508		-		87,975		2,529,266
	Patents		120		717,846		107,415		3,123,016		-		3,733,447
	Acquired technology		60		7,270,000		3,556,250		-		-		3,713,750
	Customer relationships		60-72		12,850,000		6,047,708		-		-		6,802,292
	Software		36		2,095,705		2,095,705		-		-		-
	Non-compete agreements		36		212,000		212,000		-		-		-
	Trade names		24		44,000		44,000		-		-		-
	Total intangibles			$	36,240,300	$	13,796,586	$	3,123,016	$	87,975	$	25,478,755
				As of February 28, 2013
		Weighted Average Amortization Period (In months)		Carrying Amount, net of impairment write downs		Accumulated Amortization		Transfer to Held for Sale		Net Carrying Value
	Indefinite Lived Intangible:
	Trade name	Indefinite		$	8,700,000	$	-	$	-	$	8,700,000
	Definite Lived Intangible:
	Patent litigation		84		4,038,904		1,060,109		-		2,978,795
	Patents		120		4,174,306		51,356		3,500,000		622,950
	Acquired technology		60		7,270,000		2,465,750		-		4,804,250
	Customer relationships		60-72		12,850,000		4,143,958		-		8,706,042
	Software		36		2,095,705		2,095,705		-		-
	Non-compete agreements		36		212,000		212,000		-		-
	Trade names		24		44,000		44,000		-		-
	Total intangibles			$	39,384,915	$	10,072,878	$	3,500,000	$	25,812,037
Expected future amortization	'
	Remainder of 2014	$	1,338,436
	2015		5,269,995
	2016		4,982,069
	2017		2,910,246
	2018		447,827
	Thereafter		1,830,182
	Total	$	16,778,755

ORGANIZATION_AND_BASIS_OF_PRES2

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) (USD $)	9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Feb. 28, 2013
Notes to Financial Statements	'	'	'
Accumulated deficit	($126,061,978)	'	($111,393,544)
Revolving loan facility line of credit	5,000,000	'	'
Borrowing base	90.00%	'	'
Line of credit borrowed	1,400,000	'	'
Line of credit available	3,200,000	'	'
Financing transaction amount	8,969,065	6,162,455	'
Proceeds from financing transaction	9,000,000	'	'
Financing transaction investors	'13	'	'
Common stock sold	23,875,000	'	'
Warrants issued	7,162,500	'	'
Warrant term	'5 years	'	'
Warrant exercise price	$0.60	'	'
Unissued shares value	$41,400,000	'	'

RESTATEMENT_OF_PREVIOUSLY_ISSU2

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details Narrative) (USD $)	3 Months Ended	9 Months Ended		12 Months Ended
	Nov. 30, 2013	Nov. 30, 2013	Nov. 30, 2012	Feb. 29, 2012
Restatement Of Previously Issued Financial Statements Details Narrative	'	'	'	'
Increase to goodwill	$13,500,000	($25,900,000)	'	'
Increase to deferred tax liability	13,500,000	'	'	13,500,000
Increase to income tax benefits	10,000,000	'	2,600,000	10,000,000
Increase to the identified intangible asset	'	'	$2,600,000	'

RESTATEMENT_OF_PREVIOUSLY_ISSU3

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) (USD $)	3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012	Feb. 28, 2013
Balance Sheet	'	'	'	'	'
Goodwill	$35,060,183	'	$35,060,183	'	$35,060,183
Intangible assets, net	25,478,755	'	25,478,755	'	25,812,037
Total assets	72,948,355	'	72,948,355	'	75,739,162
Total liabilities	12,088,547	'	12,088,547	'	11,877,952
Accumulated deficit	-126,061,978	'	-126,061,978	'	-111,393,544
Total stockholder's equity	60,859,808	'	60,859,808	'	63,861,210
Total liabilities and stockhollers equity	72,948,355	'	72,948,355	'	75,739,162
Statement of Cash Flows	'	'	'	'	'
Goodwill impairment	'	25,919,000	'	25,919,000	'
Statement of Shareholders Equity	'	'	'	'	'
Stockholders' equity	60,859,808	'	60,859,808	'	63,861,210
Statement of Operations	'	'	'	'	'
Goodwill impairment	'	25,919,000	'	25,919,000	'
Income tax benefit	'	'	'	2,618,723	'
Net loss	-5,278,975	-33,706,070	-14,668,434	-40,947,941	'
Basic and diluted net loss per share	($0.04)	($0.31)	($0.11)	($0.41)	'
Previously Rept [Member]	'	'	'	'	'
Balance Sheet	'	'	'	'	'
Goodwill	'	47,484,708	'	47,484,708	'
Intangible assets, net	'	30,489,139	'	30,489,139	'
Total assets	'	90,274,094	'	90,274,094	'
Deferred income tax liability	'	'	'	'	'
Total liabilities	'	9,097,712	'	9,097,712	'
Accumulated deficit	'	-87,362,012	'	-87,362,012	'
Total stockholder's equity	'	81,176,382	'	81,176,382	'
Total liabilities and stockhollers equity	'	90,274,094	'	90,274,094	'
Statement of Cash Flows	'	'	'	'	'
Net loss	'	'	'	-14,828,941	'
Goodwill impairment	'	'	'	'	'
Impairment of intangible assets	'	'	'	5,849,160	'
Statement of Shareholders Equity	'	'	'	'	'
Accumulated deficit	'	-87,362,012	'	-87,362,012	'
Stockholders' equity	'	81,176,382	'	81,176,382	'
Statement of Operations	'	'	'	'	'
Goodwill impairment	'	'	'	'	'
Impairment of intangible assets	'	'	'	5,849,160	'
Income tax benefit	'	'	'	'	'
Net loss	'	'	'	-14,828,941	'
Basic and diluted net loss per share	'	'	'	($0.15)	'
Adjmts [Member]	'	'	'	'	'
Balance Sheet	'	'	'	'	'
Goodwill	'	-12,424,525	'	-12,424,525	'
Intangible assets, net	'	-200,000	'	-200,000	'
Total assets	'	-12,624,525	'	-12,624,525	'
Deferred income tax liability	'	3,517,652	'	3,517,652	'
Total liabilities	'	3,517,652	'	3,517,652	'
Accumulated deficit	'	-16,142,177	'	-16,142,177	'
Total stockholder's equity	'	-16,142,177	'	-16,142,177	'
Total liabilities and stockhollers equity	'	-12,624,525	'	-12,624,525	'
Statement of Cash Flows	'	'	'	'	'
Net loss	'	'	'	-26,119,001	'
Goodwill impairment	'	'	'	25,919,000	'
Impairment of intangible assets	'	'	'	2,818,723	'
Statement of Shareholders Equity	'	'	'	'	'
Accumulated deficit	'	-16,142,177	'	-16,142,177	'
Stockholders' equity	'	-16,142,177	'	-16,142,177	'
Statement of Operations	'	'	'	'	'
Goodwill impairment	'	'	'	25,919,000	'
Impairment of intangible assets	'	'	'	2,818,723	'
Income tax benefit	'	'	'	2,618,723	'
Net loss	'	'	'	-26,119,001	'
Basic and diluted net loss per share	'	'	'	($0.26)	'
AsRestated [Member]	'	'	'	'	'
Balance Sheet	'	'	'	'	'
Goodwill	'	35,060,183	'	35,060,183	'
Intangible assets, net	'	30,289,139	'	30,289,139	'
Total assets	'	77,649,569	'	77,649,569	'
Deferred income tax liability	'	3,517,652	'	3,517,652	'
Total liabilities	'	12,615,364	'	12,615,364	'
Accumulated deficit	'	-103,504,189	'	-103,504,189	'
Total stockholder's equity	'	65,034,205	'	65,034,205	'
Total liabilities and stockhollers equity	'	77,649,569	'	77,649,569	'
Statement of Cash Flows	'	'	'	'	'
Net loss	'	'	'	-40,947,942	'
Goodwill impairment	'	'	'	25,919,000	'
Impairment of intangible assets	'	'	'	8,667,883	'
Statement of Shareholders Equity	'	'	'	'	'
Accumulated deficit	'	-103,504,189	'	-103,504,189	'
Stockholders' equity	'	65,034,205	'	65,034,205	'
Statement of Operations	'	'	'	'	'
Goodwill impairment	'	'	'	25,919,000	'
Impairment of intangible assets	'	'	'	8,667,883	'
Income tax benefit	'	'	'	2,618,723	'
Net loss	'	'	'	-40,947,942	'
Basic and diluted net loss per share	'	'	'	($0.41)	'
Previously Reported [Member]	'	'	'	'	'
Statement of Cash Flows	'	'	'	'	'
Net loss	'	-4,968,347	'	'	'
Goodwill impairment	'	'	'	'	'
Impairment of intangible assets	'	5,849,160	'	'	'
Statement of Operations	'	'	'	'	'
Goodwill impairment	'	'	'	'	'
Impairment of intangible assets	'	5,849,160	'	'	'
Income tax benefit	'	'	'	'	'
Net loss	'	-4,968,347	'	'	'
Basic and diluted net loss per share	'	($0.05)	'	'	'
Adjmts [Member]	'	'	'	'	'
Statement of Cash Flows	'	'	'	'	'
Net loss	'	-28,737,724	'	'	'
Goodwill impairment	'	25,919,000	'	'	'
Impairment of intangible assets	'	2,818,723	'	'	'
Statement of Operations	'	'	'	'	'
Goodwill impairment	'	25,919,000	'	'	'
Impairment of intangible assets	'	2,818,723	'	'	'
Income tax benefit	'	'	'	'	'
Net loss	'	-28,737,724	'	'	'
Basic and diluted net loss per share	'	($0.26)	'	'	'
AsRestated[Member]	'	'	'	'	'
Statement of Cash Flows	'	'	'	'	'
Net loss	'	-33,706,071	'	'	'
Goodwill impairment	'	25,919,000	'	'	'
Impairment of intangible assets	'	8,667,883	'	'	'
Statement of Operations	'	'	'	'	'
Goodwill impairment	'	25,919,000	'	'	'
Impairment of intangible assets	'	8,667,883	'	'	'
Income tax benefit	'	'	'	'	'
Net loss	'	($33,706,071)	'	'	'
Basic and diluted net loss per share	'	($0.31)	'	'	'

STOCKHOLDERS_EQUITY_Details_Na

STOCKHOLDERS' EQUITY (Details Narrative) (USD $)	9 Months Ended				8 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2013	Nov. 30, 2013
			Director [Member]	Consultant [Member[	Legal Counsel [Member]
Financing transaction amount	$8,969,065	$6,162,455	'	'	'
Financing transaction investors	'13	'	'	'	'
Financing transaction price per share	$0.40	'	'	'	'
Common stock sold	23,875,000	'	'	'	'
Warrants issued	7,162,500	'	'	'	'
Warrant term	'5 years	'	'	'	'
Warrant exercise price	$0.60	'	'	'	'
Common stock issued pursuant to compensation plan	2,069,725	'	183,800	'	'
Shares issued for services	354,310	'	'	100,000	500,000

SHAREBASED_PAYMENT_Details

SHARE-BASED PAYMENT (Details) (USD $)	3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Total stock-based compensation expense	$485,685	$1,376,102	$2,364,399	$4,302,359
Sales and Marketing Expenses [Member]	'	'	'	'
Total stock-based compensation expense	263,619	379,756	'	'
Technology and Development [Member]	'	'	'	'
Total stock-based compensation expense	126,652	272,621	635,557	882,591
General and Administrative Expenses [Member]	'	'	'	'
Total stock-based compensation expense	95,414	723,725	'	'
Selling and Marketing Expense [Member]	'	'	'	'
Total stock-based compensation expense	'	'	854,750	1,407,393
General and Administrative Expense [Member]	'	'	'	'
Total stock-based compensation expense	'	'	$874,092	$2,012,375

SHAREBASED_PAYMENT_Details_1

SHARE-BASED PAYMENT (Details 1) (USD $)	Nov. 30, 2013
Pre-Modification [Member]	'
Weighted-average exercise price	$2.40
Expected term (in years)	'3 years
Weighted-average volatility	70.00%
Risk-free rate	0.79%
Expected dividends	0.00%
Post-Modification [Member]	'
Weighted-average exercise price	$0.42
Expected term (in years)	'2 years
Weighted-average volatility	70.00%
Risk-free rate	0.39%
Expected dividends	0.00%

SHAREBASED_PAYMENT_Details_2

SHARE-BASED PAYMENT (Details 2)	3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Expected term (in years)	'	'	'2 years 11 months 30 days	'
Stock Options [Member]	'	'	'	'
Expected dividends	0.00%	0.00%	0.00%	0.00%
Expected term (in years)	'3 years 6 months	'3 years 6 months	'2 years 10 months 20 days	'3 years 6 months
Weighted-average volatility	70.00%	65.00%	70.00%	62.00%
Risk-free interest rate	0.84%	0.43%	0.55%	0.44%

SHAREBASED_PAYMENT_Details_3

SHARE-BASED PAYMENT (Details 3) (USD $)	9 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Outstanding, Beginning of Period	17,373,932
Granted	3,067,262
Exercised	'
Cancelled	-5,638,549
Forfeited	-3,245,757
Outstanding, End of Period	11,556,888
Options vested and expected to vest, ending	11,259,486
Exercisable, End of period	9,573,847
Weighted Average Exercise Price, Outstanding, Beginning of period	$2
Granted	$0.43
Exercised	'
Cancelled	$2.46
Forfeited	$2.21
Weighted Average Exercise Price, Outstanding, End of period	$1.31
Weighted Average Exercise Price, Options vested and expected to vest, ending	$1.32
Weighted Average Exercise Price, Exercisable, End of period	$1.47
Average remaining contractual term	'2 years 11 months 30 days
Average remaining contractual term exercisable Options vested and expected to vest	'2 years 2 months 23 days
Average remaining contractual term exercisable	'1 year 8 months 23 days

SHAREBASED_PAYMENT_Details_4

SHARE-BASED PAYMENT (Details 4)	3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Expected term (in years)	'	'	'2 years 11 months 30 days	'
Warrant [Member]	'	'	'	'
Expected dividends	0.00%	0.00%	0.00%	0.00%
Expected term (in years)	'0 years	'5 years	'3 years 6 months 11 days	'4 years 9 months
Weighted-average volatility	0.00%	65.00%	70.00%	64.00%
Risk-free interest rate	0.00%	0.62%	10.60%	0.59%

SHAREBASED_PAYMENT_Details_5

SHARE-BASED PAYMENT (Details 5) (USD $)	9 Months Ended		3 Months Ended		9 Months Ended
	Nov. 30, 2013	Feb. 28, 2013	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
			Warrant [Member]	Warrant [Member]	Warrant [Member]	Warrant [Member]
Warrants, Outstanding, Beginning of period	'	'	'	'	19,171,104	'
Granted	3,067,262	'	'	'	8,740,668	'
Exercised	'	'	'	'	'	'
Forfeited and expired	-3,245,757	'	'	'	-712,361	'
Outstanding, End of Period	11,556,888	17,373,932	27,199,411	'	27,199,411	'
Warrants, Vested and expected to vest, End of period	'	'	27,199,411	'	27,199,411	'
Exercisable, End of period	9,573,847	'	26,378,577	'	26,378,577	'
Weighted Average Exercise Price, Outstanding, Beginning of period	'	'	'	'	$1.32	'
Granted	$0.43	'	'	'	$0.61	'
Exercised	'	'	'	'	'	'
Forfeited and expired	$2.21	'	'	'	$1.80	'
Weighted Average Exercise Price, Outstanding, End of period	$1.31	$2	$1.06	'	$1.06	'
Weighted Average Exercise Price, Vested and expected to vest, End of period	'	'	$1.07	'	$1.07	'
Weighted Average Exercise Price, Exercisable, End of period	$1.47	'	$1.07	'	$1.07	'
Average remaining contractual term, Oustanding, Beginning of period	'2 years 11 months 30 days	'	'0 years	'5 years	'3 years 6 months 11 days	'4 years 9 months
Average remaining contractual term, Oustanding, End of period	'	'	'	'	'3 years 7 months 24 days	'
Average remaining contractual term, Vested and expected to vest, End of period	'1 year 8 months 23 days	'	'	'	'3 years 7 months 23 days	'
Average remaining contractual term, Exercisable, End of period	'	'	'	'	'3 years 7 months 23 days	'

SHAREBASED_PAYMENT_Details_Nar

SHARE-BASED PAYMENT (Details Narrative) (USD $)	9 Months Ended
	Nov. 30, 2013
Stock Options [Member]	'
Option exchanged by participants	5,460,424
New options issued following option exchange	1,261,710
Exchange options exercise price	$0.42
Exchange options vested at grant date	846,516
Unvested at grant date	415,194
Options issued covering shares of common stock	15,000,000
Stock options and restricted shares outstanding	7,600,000
Unrecognized share-based payment expense	$1,400,000
Weighted average period of share-based compensation expense	'2 years 3 months 18 days
Aggregate intrinsic value of the exercisable options	196,100
Aggregate intrinsic market value of the exercisable options, Per share	$0.53
Exercise prices of options outstanding, Lower limit	$0.25
Exercise prices of options outstanding, upper limit	$3.90
Weighted average fair value of options granted	$0.25
Warrant [Member]	'
Unrecognized share-based payment expense	107,971
Weighted average period of share-based compensation expense	'1 year 10 months 24 days
Aggregate intrinsic value of the exercisable options	$42,000
Aggregate intrinsic market value of the exercisable options, Per share	$0.53
Exercise prices of options outstanding, Lower limit	$0.39
Exercise prices of options outstanding, upper limit	$4

NET_LOSS_PER_SHARE_Details_Nar

NET LOSS PER SHARE (Details Narrative)	Nov. 30, 2013	Nov. 30, 2012
Net Loss Per Share Details Narrative	'	'
Potentially dilutive securities of options exercisable	3,100,000	2,200,000
Warrants exercisable	300,000	0

AQUISITIONS_Details_Narrative

AQUISITIONS (Details Narrative) (USD $)	9 Months Ended			9 Months Ended
	Nov. 30, 2012	Nov. 30, 2013	Feb. 28, 2013	Nov. 30, 2013	Nov. 30, 2013
				GEOS IP [Member]	Hipcricket
Acquisition consideration:	'	'	'	'	'
Patents acquired	'	'	'	$5	'
Fair value	'	'	'	4,200,000	62,800,000
Cash paid	'	'	'	355,000	3,000,000
Common stock issued, value	'	'	'	3,800,000	35,500,000
Common stock issued	'	15,458	12,955	1,860,465	11,457,359
Common stock issued, price per share	'	'	'	$2.05	$3.10
Common stock shares held in escrow	'	'	'	1,900,000	'
Escrow period	'	'	'	'1 year 2 months	'
Assets acquired, liabilities assumed and goodwill:	'	'	'	'	'
Earn out payment minimum	'	'	'	'	15,000,000
Earn out payment maximum	'	'	'	'	27,500,000
Total assets acquired and liabilities assumed	'	'	'	'	25,200,000
Increase to the identified intangible asset	2,600,000	'	'	2,600,000	'
Total acquisition consideration	'	'	'	'	23,300,000
Current liabilities	'	'	'	'	$2,000,000

INTANGIBLE_ASSETS_Details

INTANGIBLE ASSETS (Details) (USD $)	Nov. 30, 2013	Feb. 28, 2013
Gross carrying value	$36,240,300	$39,384,915
Accumulated Amortization	13,796,586	10,072,878
Transfer to Held For Sale	3,123,016	'
Impairment Loss	87,975	'
Net Carrying Value	25,478,755	25,812,037
Patent litigation	'	'
Weighted Average Amortization Period (In months)	'84 months	'84 months
Gross carrying value	4,350,749	4,038,904
Accumulated Amortization	1,733,508	1,060,109
Transfer to Held For Sale	'	'
Impairment Loss	87,975	'
Net Carrying Value	2,529,266	2,978,795
Patents	'	'
Weighted Average Amortization Period (In months)	'120 months	'120 months
Gross carrying value	717,846	4,174,306
Accumulated Amortization	107,415	51,356
Transfer to Held For Sale	3,123,016	3,500,000
Impairment Loss	'	'
Net Carrying Value	3,733,447	622,950
Acquired technology	'	'
Weighted Average Amortization Period (In months)	'60 months	'60 months
Gross carrying value	7,270,000	7,270,000
Accumulated Amortization	3,556,250	2,465,750
Transfer to Held For Sale	'	'
Impairment Loss	'	'
Net Carrying Value	3,713,750	4,804,250
Customer relationships	'	'
Gross carrying value	12,850,000	12,850,000
Accumulated Amortization	6,047,708	4,143,958
Transfer to Held For Sale	'	'
Impairment Loss	'	'
Net Carrying Value	6,802,292	8,706,042
Customer relationships | Minimum [Member]	'	'
Weighted Average Amortization Period (In months)	'60 months	'60 months
Customer relationships | Maximum [Member]	'	'
Weighted Average Amortization Period (In months)	'72 months	'72 months
Software	'	'
Weighted Average Amortization Period (In months)	'36 months	'36 months
Gross carrying value	2,095,705	2,095,705
Accumulated Amortization	2,095,705	2,095,705
Transfer to Held For Sale	'	'
Impairment Loss	'	'
Net Carrying Value	'	'
Non-compete agreements	'	'
Weighted Average Amortization Period (In months)	'36 months	'36 months
Gross carrying value	212,000	212,000
Accumulated Amortization	212,000	212,000
Transfer to Held For Sale	'	'
Impairment Loss	'	'
Net Carrying Value	'	'
Trade names	'	'
Weighted Average Amortization Period (In months)	'24 months	'24 months
Gross carrying value	44,000	44,000
Accumulated Amortization	44,000	44,000
Transfer to Held For Sale	'	'
Impairment Loss	'	'
Net Carrying Value	'	'
Indefinite Trade Name	'	'
Gross carrying value	8,700,000	8,700,000
Accumulated Amortization	'	'
Transfer to Held For Sale	'	'
Impairment Loss	'	'
Net Carrying Value	$8,700,000	$8,700,000

INTANGIBLE_ASSETS_Details_1

INTANGIBLE ASSETS (Details 1) (USD $)	Nov. 30, 2013
Intangible Assets Details 1	'
Remainder of 2014	$1,338,436
2015	5,269,995
2016	4,982,069
2017	2,910,246
2018	447,827
Thereafter	1,830,182
Total	$16,778,755

INTANGIBLE_ASSETS_Details_Narr

INTANGIBLE ASSETS (Details Narrative) (USD $)	3 Months Ended	9 Months Ended	3 Months Ended
	Nov. 30, 2013	Nov. 30, 2013	Nov. 30, 2013	Nov. 30, 2012
			Millenial [Member]	GEOS JagTag [Member]
Fair value of patents held for sale	'	'	'	$35,000,000
Intangible assets reclassified to held and used	3,120,000	'	'	'
Asset impairment charge upon reclassification	376,984	'	'	'
Litigation impairment charge	'	'	87,975	'
Carrying value of the acquired patents	'	8,700,000	'	'
Amortization of intangible assets	$1,300,000	$3,800,000	'	'

CONTINGENCIES_Details_Narrativ

CONTINGENCIES (Details Narrative) (USD $)	Nov. 30, 2013
Contingencies Details Narrative	'
Litigation amount	$2,249,686

LINE_OF_CREDIT_Details_Narrati

LINE OF CREDIT (Details Narrative) (USD $)	9 Months Ended
	Nov. 30, 2013
Debt Disclosure [Abstract]	'
Revolving loan facility line of credit	$5,000,000
Borrowing base	90.00%
Per annum rate	1.25%
Unrestricted cash under facility	400000000.00%
Quarterly fee rate	0.25%
Line of credit borrowed	1,400,000
Line of credit available	$3,200,000
Minimum tangible net worth	125.00%

CONCENTRATION_OF_RISK_Details_

CONCENTRATION OF RISK (Details Narrative)	3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Customer One [Member]	'	'	'	'
Revenue major customer percentage	7.00%	9.00%	600.00%	10.00%
Customer Two [Member]	'	'	'	'
Revenue major customer percentage	6.00%	6.00%	5.00%	70.00%
Customer Three [Member]	'	'	'	'
Revenue major customer percentage	'	5.00%	'	'
No Other Customers [Member]	'	'	'	'
Revenue major customer percentage	5.00%	'	'	'
No Other Customer [Member]	'	'	'	'
Revenue major customer percentage	'	5.00%	5.00%	5.00%
Four Customers [Member]	'	'	'	'
Customers accounted accounts receivables	25.00%	'	25.00%	'
Largest Customer [Member]	'	'	'	'
Customers accounted accounts receivables	11.00%	'	11.00%	'
Three Customers [Member]	'	'	'	'
Customers accounted accounts receivables	'	29.00%	'	29.00%
Largest Customer [Member]	'	'	'	'
Customers accounted accounts receivables	'	12.00%	'	12.00%